STOCK TITAN

NANO-X IMAGING LTD Ordinary Shares - $NNOX STOCK NEWS

Welcome to our dedicated page for NANO-X IMAGING Ordinary Shares news (Ticker: $NNOX), a resource for investors and traders seeking the latest updates and insights on NANO-X IMAGING Ordinary Shares stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NANO-X IMAGING Ordinary Shares's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NANO-X IMAGING Ordinary Shares's position in the market.

Rhea-AI Summary
NANO-X IMAGING postpones Investor Day due to recent events in Israel
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.96%
Tags
none
-
Rhea-AI Summary
NANO-X IMAGING LTD enters into a manufacture and supply agreement with Varex Imaging Corporation to supply X-ray tubes for the Nanox.ARC system. Nanox believes the digital cathode X-ray source can achieve the same functionalities as legacy X-ray cathodes at a lower cost. Nanox intends to add AI technology in the future. Varex will receive a revenue-sharing fee based on Nanox's pay-per-scan revenue. Nanox received FDA clearance to market the Nanox.ARC system. Nanox.ARC systems have been installed in Nigeria, Morocco, and Ghana for demonstration and training purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.94%
Tags
none
-
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) to host Investor Day at Nasdaq on Oct. 17, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.74%
Tags
conferences
Rhea-AI Summary
Nanox.AI's HealthCCSng solution used in study finds 58% of patients had moderate to severe levels of coronary artery calcium (CAC), a predictor of future cardiac events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.24%
Tags
AI
-
Rhea-AI Summary
Nanox to participate in Cantor Fitzgerald Global Healthcare Conference 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
-
Rhea-AI Summary
Nanox reports Q2 2023 results with $2.6M revenue and $17.4M net loss. Received FDA clearance for Nanox.ARC system. Progress in securing chip and tube supplies. Raised $30M in direct offering.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.09%
Tags
Rhea-AI Summary
NANO-X IMAGING LTD (Nasdaq: NNOX) will report its Q2 2023 financial results on August 17, 2023. The conference call to review the results and provide a business update will be hosted by CEO Erez Meltzer and CFO Ran Daniel at 8:30 a.m. ET. Interested parties can register for the conference call and access the live webcast through the Investor Relations section of the Nanox website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.46%
Tags
conferences earnings
-
Rhea-AI Summary
NANO-X IMAGING LTD has entered into a securities purchase agreement with institutional investors for the purchase and sale of 2,142,858 ordinary shares, along with warrants to purchase up to 2,142,858 ordinary shares. The combined purchase price is $14.00 per share, with the warrants having an exercise price of $19.00 per share. The offering is expected to close soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.21%
Tags
-
Rhea-AI Summary
NANO-X IMAGING LTD (NASDAQ: NNOX) reported $2.4 million in revenue for Q1 2023, an increase from $1.8 million in Q1 2022. The company received FDA clearance to market the Nanox.ARC as a stationary X-ray system. They also obtained ISO 13485 certification for their Korean fabrication facility. Nanox is working to establish a demo center in Florida and entered into a distribution agreement with Vital Tech SARL to deploy 270 Nanox.ARC units in Morocco. The company reported a net loss of $11.8 million for Q1 2023, compared to $21.7 million in the same period last year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.3%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.87%
Tags
conferences earnings
NANO-X IMAGING LTD Ordinary Shares

Nasdaq:NNOX

NNOX Rankings

NNOX Stock Data

533.88M
55.12M
9.13%
22.76%
15.35%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
Neve Ilan

About NNOX

nanox is developing the next generation of x-ray emitters based on groundbreaking nanotechnology. nanox emitters will finally bring x-ray imaging into the digital era, enabling novel 3d imaging systems with unmatched performance